A nurse is caring for a patient with acute kidney injury (AKI). Which assessment finding would be the MOST concerning and require immediate intervention?

Hyperkalemia (serum potassium >5.5 mEq/L) is a life-threatening complication of AKI requiring immediate intervention due to risk of fatal cardiac arrhythmias. Other findings (elevated BUN, creatinine, oliguria) are concerning but less urgent.

Clinical Reasoning and Prioritization in Acute Kidney Injury

The most concerning assessment finding requiring immediate intervention is the serum potassium level of 6.8 mEq/L. This value represents severe, life-threatening hyperkalemia. While all the listed findings are abnormal and consistent with acute kidney injury (AKI), the critical serum potassium level poses the most immediate risk for cardiac arrest and must be addressed before the other issues.

The rationale for this prioritization is rooted in the electrophysiological dangers of severe hyperkalemia and its role in a dangerous clinical spiral. The provided evidence describes BRASH syndrome (Bradycardia, Renal failure, Atrioventricular nodal blockade, Shock, and Hyperkalemia), a concept that perfectly illustrates why this potassium level is the priority [1,2]. In this syndrome, hyperkalemia does not act in isolation. It creates a synergistic and self-perpetuating "vicious cycle" with renal failure and AV nodal blockade [1,2]. A patient with AKI cannot excrete potassium efficiently, leading to hyperkalemia. The elevated potassium directly depresses cardiac conduction, potentiating the effects of any AV nodal blocking agents the patient may be taking, which leads to profound bradycardia and reduced cardiac output ^[1]. This hemodynamic instability further worsens kidney perfusion and function, which in turn exacerbates the hyperkalemia [1,2]. A potassium level of 6.8 mEq/L places the patient at extreme risk for this cycle to rapidly deteriorate into hemodynamic collapse and cardiac arrest.

It is a critical teaching point that the absence of classic electrocardiographic (EKG) changes does not rule out life-threatening hyperkalemia. A case highlighted in the evidence describes a patient with a serum potassium of 8.7 mmol/L who presented without any EKG abnormalities or overt symptoms ^[3]. This underscores that clinical presentation does not always correlate with biochemical severity, and a laboratory value of this magnitude demands urgent, guideline-driven intervention based on the number itself, regardless of the EKG tracing ^[3].

In comparison, the other options, while significant, are less immediately lethal. An elevated BUN of 45 mg/dL and serum creatinine of 2.8 mg/dL indicate the severity of the AKI and contribute to the uremic milieu that can overlap symptomatically with hyperkalemia, such as causing nausea ^[3]. However, the uremic toxins themselves do not cause sudden cardiac arrest in the way a potassium level of 6.8 mEq/L can. Similarly, a urine output of 350 mL in 24 hours defines oliguria and confirms the intrinsic renal injury, but the immediate threat to life from this low output is the accumulation of electrolytes like potassium, which is the direct problem that must be treated first. The management of BRASH syndrome reinforces this, as the condition is often refractory to standard bradycardia treatments and only improves when the hyperkalemia is directly addressed as the central trigger ^[2].